HCID 57420172, 화합물 → HCID 57420174, 화합물
반응식
[Cl:1][C:2]1[C:7]([Cl:8])=[CH:6][CH:5]=[CH:4][C:3]=1[N:9]1[CH2:14][CH2:13][N:12]([CH2:15][CH2:16][CH2:17][C:18]([O:20][C:21]2[CH:30]=[C:29]3[C:24]([CH2:25][CH2:26][C:27](=[O:31])[NH:28]3)=[CH:23][CH:22]=2)=[O:19])[CH2:11][CH2:10]1.Cl.COC1C=CC=CC=1N1CCN(CCCC(OC2C=C3C(CCC(=O)N3)=CC=2)=O)CC1>>[ClH:1].[Cl:1][C:2]1[C:7]([Cl:8])=[CH:6][CH:5]=[CH:4][C:3]=1[N:9]1[CH2:10][CH2:11][N:12]([CH2:15][CH2:16][CH2:17][C:18]([O:20][C:21]2[CH:30]=[C:29]3[C:24]([CH2:25][CH2:26][C:27](=[O:31])[NH:28]3)=[CH:23][CH:22]=2)=[O:19])[CH2:13][CH2:14]1참가 물질
3
실험 절차
2-Oxo-1,2,3,4-tetrahydroquinolin-7-yl 4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butanoate hydrochloride (20b) (Scheme 3) was prepared from the compound 19b according to the protocol described for the compound 20a (Example 29). The hydrochloride salt 20b gave satisfactory 1H NMR spectral data. White solid, 0.11 g (98%). MS (ESI): m/z=462.1 (M+).
출처 및 근거
- ORD 기록
- ord-90ede9d1dad9465aac6f9404582fbb49
- 출처 데이터셋
- uspto-grants-2012_08
- 특허 번호
- US08247420B2
반응 노트
불러오는 중…